Abstract
This chapter contains the core of the innate immune defense systems and consequently marks the most voluminous chapter of the book. It consists of an initial recognition part and a subsequent executive part. Perception of infectious or sterile injury is ensured by PRM-bearing innate immune cells which possess the property to recognize MAMPs and DAMPs. Following recognition, the various cell-bound PRMs including TLRs, NLRs, RLRs, and ALRs trigger signalling pathways which promote, via strictly regulated transcriptional and translational processes, the secretion of mediator substances to elicit efferent inflammatory responses. Intracellular formation of multiprotein complexes, the inflammasomes, plays a pivotal role in the establishment of the inflammatory milieu. Among the vital mediator substances of inflammation, several families of pro-inflammatory or anti-inflammatory cytokines such as the interleukin-1 family, interferons, tumor necrosis factor, and interleukin-17 family, as well as the chemokine family, take center stage in shaping and regulating promotion and resolution of inflammation. The efforts of all these substances in ensuring effective defense are supported and complemented by the process of phagocytosis that can be recognized as one of the critical biological events of the innate immune defense system mainly executed by the “professionals” among phagocytosing cells, the macrophages, neutrophils, and dendritic cells. In fact, dangerous foreign bodies such as bacteria or fungi as well as apoptotic and necrotic cells can be cleared from infectiously or sterilely damaged tissue by these professional phagocytes. The chapter closes with the notoriously repeated comment that all these sophisticated pathways of a robust innate immune defense may lead to pathologies and many human diseases, when they take place in an uncontrolled and dysregulated way.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nathan C. Points of control in inflammation. Nature. 2002;420:846–52. Available from: http://www.nature.com/doifinder/10.1038/nature01320
Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–35. Available from: http://www.nature.com/doifinder/10.1038/nature07201
Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871–82. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867410001820
Martin AJ. Academy papyrus to be exhibited at the metropolitan museum of art. New York: The New York Academy of Medicine; 2005. Available from: http://www.nyam.org/news/2493.html
Google Image Result. Available from: https://upload.wikimedia.org/wikipedia/commons/thumb/e/e4/PEbers_c41-bc.jpg/250px-PEbers_c41-bc.jpg. http://images.google.de/imgres?imgurl=https://upload.wikimedia.org/wikipedia/commons/thumb/e/e4/PEbers_c41-bc.jpg/250px-PEbers_c41-bc.jpg&imgrefurl
Full text of “Handbuch der Geschichte der Medizin. Bearb. von Arndt [et al.]”. Available from: https://archive.org/stream/handbuchdergesch01puscuoft/handbuchdergesch01puscuoft_djvu.txt
Virchow R. Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. 1. Auflage. Berlin; 1858. Available from: http://www.deutschestextarchiv.de/book/show/virchow_cellularpathologie_1858
Browning CH. Emil Behring and Paul Ehrlich: their contributions to science. Nature. 1955;175:616–9; concl. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14370180
Schmalstieg FC, Goldman AS. Birth of the science of immunology. J Med Biogr. 2010;18:88–98. Available from: http://journals.sagepub.com/doi/10.1258/jmb.2010.010009
Silverstein A. A history of immunology. 2nd ed. Amsterdam: Academic Press/Elsevier; 2009. Available from: https://www.elsevier.com/books/a-history-of-immunology/silverstein/978-0-12-370586-0
Mendelsohn JA. “Like all that lives”: biology, medicine and bacteria in the age of Pasteur and Koch. Hist Philos Life Sci. 2002;24:3–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12664951
Kulkarni OP, Lichtnekert J, Anders H-J, Mulay SR. The immune system in tissue environments regaining homeostasis after injury: is “inflammation” always inflammation? Mediat Inflamm. 2016;2016:1–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27597803
Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140:771–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867410002424
Rivera A, Siracusa MC, Yap GS, Gause WC. Innate cell communication kick-starts pathogen-specific immunity. Nat Immunol. 2016;17:356–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27002843
Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol. 2015;16:27–35. Available from: http://www.nature.com/doifinder/10.1038/ni.3045
Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol. 2014;15:602–11. Available from: http://www.nature.com/doifinder/10.1038/ni.2921
Lakschevitz FS, Visser MB, Sun C, Glogauer M. Neutrophil transcriptional profile changes during transit from bone marrow to sites of inflammation. Cell Mol Immunol. 2015;12:53–65. Available from: http://www.nature.com/doifinder/10.1038/cmi.2014.37
Fahey S, Dempsey E, Long A. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol. 2014;11:25–40. Available from: http://www.nature.com/doifinder/10.1038/cmi.2013.37
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–75. Available from: http://www.nature.com/doifinder/10.1038/nri3399
Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692–704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26471775
Land WG. Innate alloimmunity. Part 2: Innate immunity and allograft rejection. BaskentUniversity, Ankara; Pabst Science Publishers, Lengerich. 2011. Available from: ISBN 978-3-89967-738-6.
Schmidt S, Moser M, Sperandio M. The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol. 2013;55:49–58. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161589012004646
Muller WA. The regulation of transendothelial migration: new knowledge and new questions. Cardiovasc Res. 2015;107:310–20. Available from: https://academic.oup.com/cardiovascres/article-lookup/doi/10.1093/cvr/cvv145
Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–61. Available from: http://www.nature.com/doifinder/10.1038/nri2294
Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of inflammation: what controls its onset? Front Immunol. 2016;7:160. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2016.00160/abstract
O’Callaghan G, Houston A. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? Br J Pharmacol. 2015;172:5239–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26377664
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta Mol Cell Biol Lipids. 2015;1851:414–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25038274
Hangai S, Ao T, Kimura Y, Matsuki K, Kawamura T, Negishi H, et al. PGE2 induced in and released by dying cells functions as an inhibitory DAMP. Proc Natl Acad Sci U S A. 2016;113:3844–9. Available from: http://www.pnas.org/lookup/doi/10.1073/pnas.1602023113
Koga K, Takaesu G, Yoshida R, Nakaya M, Kobayashi T, Kinjyo I, et al. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity. 2009;30:372–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19285436
Sokolowska M, Chen L-Y, Liu Y, Martinez-Anton A, Qi H-Y, Logun C, et al. Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol. 2015;194:5472–87. Available from: http://www.jimmunol.org/lookup/doi/10.4049/jimmunol.1401343
Lima KM, Vago JP, Caux TR, Negreiros-Lima GL, Sugimoto MA, Tavares LP, et al. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1. J Biol Chem. 2017;jbc.M117.800391. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28655761
Perretti M, D’Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9:62–70. Available from: http://www.nature.com/doifinder/10.1038/nri2470
Gavins FNE, Hickey MJ. Annexin A1 and the regulation of innate and adaptive immunity. Front Immunol. 2012;3:354. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23230437
Sousa LP, Alessandri AL, Pinho V, Teixeira MM. Pharmacological strategies to resolve acute inflammation. Curr Opin Pharmacol. 2013;13:625–31. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1471489213000416
Sugimoto MA, Vago JP, Teixeira MM, Sousa LP. Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res. 2016;2016:1–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26885535
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101. Available from: http://www.nature.com/doifinder/10.1038/nature13479
Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2015;16:51–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26688348
Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014;7:a016311. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a016311
Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol. 2003;4:87–91. Available from: http://www.nature.com/doifinder/10.1038/ni871
Frasch SC, Bratton DL. Emerging roles for lysophosphatidylserine in resolution of inflammation. Prog Lipid Res. 2012;51:199–207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22465125
Frasch SC, Fernandez-Boyanapalli RF, Berry KAZ, Murphy RC, Leslie CC, Nick JA, et al. Neutrophils regulate tissue neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine. J Biol Chem. 2013;288:4583–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23293064
Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat Immunol. 2014;15:920–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25194421
Franz S, Muñoz LE, Heyder P, Herrmann M, Schiller M. Unconventional apoptosis of polymorphonuclear neutrophils (PMN): staurosporine delays exposure of phosphatidylserine and prevents phagocytosis by MΦ-2 macrophages of PMN. Clin Exp Immunol. 2015;179:75–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24995908
Griffiths HR, Gao D, Pararasa C. Redox regulation in metabolic programming and inflammation. Redox Biol. 2017;12:50–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28212523
Lemke G. Phosphatidylserine is the signal for TAM receptors and their ligands. Trends Biochem Sci. 2017;42:738–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28734578
Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26982353
Martin K, Ohayon D, Witko-Sarsat V. Promoting apoptosis of neutrophils and phagocytosis by macrophages: novel strategies in the resolution of inflammation. Swiss Med Wkly. 2015;145:w14056. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25701669
Robb CT, Regan KH, Dorward DA, Rossi AG. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol. 2016;38:425–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27116944
Biermann MHC, Podolska MJ, Knopf J, Reinwald C, Weidner D, Maueröder C, et al. Oxidative burst-dependent NETosis is implicated in the resolution of necrosis-associated sterile inflammation. Front Immunol. 2016;7:557. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2016.00557/full
Carson WF, Kunkel SL. Regulation of cellular immune responses in sepsis by histone modifications. Adv Protein Chem Struct Biol. 2017;106:191–225. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28057212
Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, et al. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One. 2013;8:e78045. Available from: http://dx.plos.org/10.1371/journal.pone.0078045
Kroetz DN, Allen RM, Schaller MA, Cavallaro C, Ito T, Kunkel SL. Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection. PLoS Pathog. 2015;11:e1005338. Available from: http://dx.plos.org/10.1371/journal.ppat.1005338
Schliehe C, Flynn EK, Vilagos B, Richson U, Swaminathan S, Bosnjak B, et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol. 2015;16:67–74. Available from: http://www.nature.com/doifinder/10.1038/ni.3046
Kapellos TS, Iqbal AJ. Epigenetic control of macrophage polarisation and soluble mediator gene expression during inflammation. Mediat Inflamm. 2016;2016:1–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27143818
Novak ML, Thorp EB. Shedding light on impaired efferocytosis and nonresolving inflammation. Circ Res. 2013;113:9–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23788501
Fredman G, Li Y, Dalli J, Chiang N, Serhan CN. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci Rep. 2012;2:639. Available from: http://www.nature.com/articles/srep00639
Deschamps M, Laval G, Fagny M, Itan Y, Abel L, Casanova J-L, et al. Genomic signatures of selective pressures and introgression from archaic hominins at human innate immunity genes. Am J Hum Genet. 2016;98:5–21. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0002929715004851
Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12524386
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20303872
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20404851
Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34:637–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21616434
Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4:a006049. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a006049
Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16:343–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25789684
Braza F, Brouard S, Chadban S, Goldstein DR. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol. 2016;12:281–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27026348
Takeda K, Akira S. Toll-Like receptors. In: Coico R, editor. Current protocols in immunology. Malden, MA: Wiley; 2015. p. 14.12.1–14.12.10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25845562.
Satoh T, Akira S. Toll-like receptor signaling and its inducible proteins. Microbiol Spectr. 2016. https://doi.org/10.1128/microbiolspec.MCHD-0040-2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28084212
Geng J, Sun X, Wang P, Zhang S, Wang X, Wu H, et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol. 2015;16:1142–52. Available from: http://www.nature.com/doifinder/10.1038/ni.3268
Stuart LM, Lacy-Hulbert A. De-Mst-ifying microbicidal killing. Nat Immunol. 2015;16:1107–8. Available from: http://www.nature.com/doifinder/10.1038/ni.3291
Barratt-Due A, Pischke SE, Nilsson PH, Espevik T, Mollnes TE. Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets. J Leukoc Biol. 2017;101:193–204. Available from: http://www.jleukbio.org/lookup/doi/10.1189/jlb.3VMR0316-132R
Lee CC, Avalos AM, Ploegh HL. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol. 2012;12:168–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22301850
Tan Y, Kagan JC. Microbe-inducible trafficking pathways that control Toll-like receptor signaling. Traffic. 2017;18:6–17. Available from: http://doi.wiley.com/10.1111/tra.12454
Kieser KJ, Kagan JC. Multi-receptor detection of individual bacterial products by the innate immune system. Nat Rev Immunol. 2017;17:376–90. Available from: http://www.nature.com/doifinder/10.1038/nri.2017.25
Pandey S, Kawai T, Akira S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol. 2014;7:a016246. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a016246
Steimle A, Autenrieth IB, Frick J-S. Structure and function: lipid A modifications in commensals and pathogens. Int J Med Microbiol. 2016;306:290–301. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1438422116300169
Guiducci C, Coffman RL, Barrat FJ. Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J Intern Med. 2009;265:43–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19093959
Miyake K, Shibata T, Ohto U, Shimizu T. Emerging roles of the processing of nucleic acids and Toll-like receptors in innate immune responses to nucleic acids. J Leukoc Biol. 2017;101:135–42. Available from: http://www.jleukbio.org/lookup/doi/10.1189/jlb.4MR0316-108R
Ramnath D, Powell EE, Scholz GM, Sweet MJ. The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair. Semin Cell Dev Biol. 2017;61:22–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27552920
Ullah MO, Sweet MJ, Mansell A, Kellie S, Kobe B. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol. 2016;100:27–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27162325
Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, et al. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity. 2010;33:583–96. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761310003523
Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell. 2011;147:868–80. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867411012219
Gay NJ, Symmons MF, Gangloff M, Bryant CE. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014;14:546–58. Available from: http://www.nature.com/doifinder/10.1038/nri3713
Kaiser WJ, Offermann MK. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol. 2005;174:4942–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15814722
He S, Liang Y, Shao F, Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A. 2011;108:20054–9. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.1116302108
Polumuri SK, Toshchakov VY, Vogel SN. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fc gamma receptor ligation in murine macrophages. J Immunol. 2007;179:236–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17579043
Utsugi M, Dobashi K, Ono A, Ishizuka T, Matsuzaki S, Hisada T, et al. PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role. J Immunol. 2009;182:5225–31. Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.0801352
Troutman TD, Bazan JF, Pasare C. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle. 2012;11:3559–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22895011
Chen C-W, Chen C-C, Jian C-Y, Lin P-H, Chou J-C, Teng H-S, et al. Attenuation of exercise effect on inflammatory responses via novel role of TLR4/PI3K/Akt signaling in rat splenocytes. J Appl Physiol. 2016;121:870–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27539497
Zhang X, Jiang D, Jiang W, Zhao M, Gan J. Role of TLR4-mediated PI3K/AKT/GSK-3 β signaling pathway in apoptosis of rat hepatocytes. Biomed Res Int. 2015;2015:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26770978
He L, Zang A, Du M, Ma D, Yuan C, Zhou C, et al. mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines. Virol Sin. 2015;30:174–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26122641
Abdel-Nour M, Tsalikis J, Kleinman D, Girardin SE. The emerging role of mTOR signalling in antibacterial immunity. Immunol Cell Biol. 2014;92:346–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24518980
Paracha RZ, Ahmad J, Ali A, Hussain R, Niazi U, Tareen SHK, et al. Formal modelling of Toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis. PLoS One. 2014;9:e108466. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25255432
Luu K, Greenhill CJ, Majoros A, Decker T, Jenkins BJ, Mansell A. STAT1 plays a role in TLR signal transduction and inflammatory responses. Immunol Cell Biol. 2014;92:761–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25027037
Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005;94:29–86. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0065230X05940025
Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–19. Available from: http://www.nature.com/doifinder/10.1038/nrg1879
Manning BD, Cantley LC, Accili D, Arden KC, Ackah E, Yu J, et al. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17604717
Lopiccolo J, Blumenthal G, Bernstein W, Dennis P. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008;11:32–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18166498
Cheng H, Shcherba M, Pendurti G, Liang Y, Piperdi B, Perez-Soler R. Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment. Lung Cancer Manag. 2014;3:67–75. Available from: http://www.futuremedicine.com/doi/10.2217/lmt.13.72
Xia P, Xu X-Y. PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015;5:1602–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26175931
Brenner A, Andersson Tvedt T, Bruserud Ø. The complexity of targeting PI3K-Akt-mTOR signalling in human acute myeloid leukaemia: the importance of leukemic cell heterogeneity, neighbouring mesenchymal stem cells and immunocompetent cells. Molecules. 2016;21:1512. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27845732
Sharma VR, Gupta GK, Sharma AK, Batra N, Sharma DK, Joshi A, et al. PI3K/Akt/mTOR intracellular pathway and breast cancer: factors, mechanism and regulation. Curr Pharm Des. 2017;23(11):1633–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27848885
Gao Y, Yuan CY, Yuan W. Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies? Stem Cell Investig. 2016;3:31. Available from: http://sci.amegroups.com/article/view/11050/11609
Asati V, Mahapatra DK, Bharti SK. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives. Eur J Med Chem. 2016;109:314–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26807863
Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood. 2000;95:19–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10607680
Leonard WJ, O’Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293–322. Available from: http://www.annualreviews.org/doi/10.1146/annurev.immunol.16.1.293
O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36:542–50. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761312001343
O’Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368:161–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23301733
Schwartz DM, Bonelli M, Gadina M, O’Shea JJ. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol. 2016;12:25–36. Available from: http://www.nature.com/doifinder/10.1038/nrrheum.2015.167
Gao Q, Liang X, Shaikh AS, Zang J, Xu W, Zhang Y. JAK/STAT signal transduction: promising attractive targets for immune, inflammatory and hematopoietic diseases. Curr Drug Targets 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27928945
Mizuguchi R, Noto S, Yamada M, Ashizawa S, Higashi H, Hatakeyama M. Ras and signal transducer and activator of transcription (STAT) are essential and sufficient downstream components of Janus kinases in cell proliferation. Jpn J Cancer Res. 2000;91:527–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10835498
Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene. 2000;19:5662–79. Available from: http://www.nature.com/doifinder/10.1038/sj.onc.1203925
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809. Available from: http://www.nature.com/doifinder/10.1038/nrc2734
Stark GR, Darnell JE. The JAK-STAT pathway at twenty. Immunity. 2012;36:503–14. Available from: http://linkinghub.elsevier.com/retrieve/pii/S107476131200132X
Buchon N, Silverman N, Cherry S. Immunity in Drosophila melanogaster—from microbial recognition to whole-organism physiology. Nat Rev Immunol. 2014;14:796–810. Available from: http://www.nature.com/doifinder/10.1038/nri3763
Shaukat Z, Liu D, Gregory S. Sterile inflammation in Drosophila. Mediat Inflamm. 2015;2015:369286. Available from: http://www.hindawi.com/journals/mi/2015/369286/
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003;4:702–7. Available from: http://www.nature.com/doifinder/10.1038/ni945
Travassos LH, Carneiro LAM, Ramjeet M, Hussey S, Kim Y-G, Magalhães JG, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55–62. Available from: http://www.nature.com/doifinder/10.1038/ni.1823
Werts C, Rubino S, Ling A, Girardin SE, Philpott DJ. Nod-like receptors in intestinal homeostasis, inflammation, and cancer. J Leukoc Biol. 2011;90:471–82. Available from: http://www.jleukbio.org/cgi/doi/10.1189/jlb.0411183
Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol. 2014;14:9–23. Available from: http://www.nature.com/doifinder/10.1038/nri3565
Shibutani ST, Saitoh T, Nowag H, Münz C, Yoshimori T. Autophagy and autophagy-related proteins in the immune system. Nat Immunol. 2015;16:1014–24. Available from: http://www.nature.com/doifinder/10.1038/ni.3273
Rauch I, Tenthorey JL, Nichols RD, Al Moussawi K, Kang JJ, Kang C, et al. NAIP proteins are required for cytosolic detection of specific bacterial ligands in vivo. J Exp Med. 2016;213:657–65. Available from: http://www.jem.org/lookup/doi/10.1084/jem.20151809
Robertson SJ, Zhou JY, Geddes K, Rubino SJ, Cho JH, Girardin SE, et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes. 2013;4:222–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23549220
Robertson SJ, Geddes K, Maisonneuve C, Streutker CJ, Philpott DJ. Resilience of the intestinal microbiota following pathogenic bacterial infection is independent of innate immunity mediated by NOD1 or NOD2. Microbes Infect. 2016;18:460–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27083475
Keestra-Gounder AM, Byndloss MX, Seyffert N, Young BM, Chávez-Arroyo A, Tsai AY, et al. NOD1 and NOD2 signalling links ER stress with inflammation. Nature. 2016;532:394–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27007849
Byndloss MX, Keestra-Gounder AM, Bäumler AJ, Tsolis RM. NOD1 and NOD2: new functions linking endoplasmic reticulum stress and inflammation. DNA Cell Biol. 2016;35:311–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27341284
Caruso R, Núñez G. Innate immunity: ER stress recruits NOD1 and NOD2 for delivery of inflammation. Curr Biol. 2016;26:R508–11. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0960982216304791
Kaparakis-Liaskos M. The intracellular location, mechanisms and outcomes of NOD1 signaling. Cytokine. 2015;74:207–12. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1043466615000770
Caruso R, Warner N, Inohara N, Núñez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41:898–908. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25526305
Juárez E, Carranza C, Hernández-Sánchez F, Loyola E, Escobedo D, León-Contreras JC, et al. Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages. BMC Pulm Med. 2014;14:152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25253572
Irving AT, Mimuro H, Kufer TA, Lo C, Wheeler R, Turner LJ, et al. The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling. Cell Host Microbe. 2014;15:623–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24746552
Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science. 2006;314:997–1001. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1132998
Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–5. Available from: http://www.nature.com/doifinder/10.1038/nature04734
Schlee M, Hartmann G. Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol. 2016;16:566–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27455396
Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 2014;32:461–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24655297
Ahlers LRH, Goodman AG. Nucleic acid sensing and innate immunity: signaling pathways controlling viral pathogenesis and autoimmunity. Curr Clin Microbiol Rep. 2016;3:132–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27857881
Vabret N, Bhardwaj N, Greenbaum BD. Sequence-specific sensing of nucleic acids. Trends Immunol. 2017;38:53–65. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1471490616301703
Hartmann G. Nucleic acid immunity. Adv Immunol. 2017;133:121–69. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28215278
Runge S, Sparrer KMJ, Lässig C, Hembach K, Baum A, García-Sastre A, et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog. 2014;10:e1004081. Available from: http://dx.plos.org/10.1371/journal.ppat.1004081
Sanchez David RY, Combredet C, Sismeiro O, Dillies M-A, Jagla B, Coppée J-Y, et al. Comparative analysis of viral RNA signatures on different RIG-I-like receptors. elife. 2016;5:e11275. Available from: http://elifesciences.org/lookup/doi/10.7554/eLife.11275
Wang Y, Ludwig J, Schuberth C, Goldeck M, Schlee M, Li H, et al. Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol. 2010;17:781–7. Available from: http://www.nature.com/doifinder/10.1038/nsmb.1863
Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. Structural insights into RNA recognition by RIG-I. Cell. 2011;147:409–22. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867411010841
Jiang F, Ramanathan A, Miller MT, Tang G-Q, Gale M, Patel SS, et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature. 2011;479:423–7. Available from: http://www.nature.com/doifinder/10.1038/nature10537
Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity. 2009;31:25–34. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761309002714
Ahmad S, Hur S. Helicases in antiviral immunity: dual properties as sensors and effectors. Trends Biochem Sci. 2015;40:576–85. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0968000415001413
Belgnaoui SM, Paz S, Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol. 2011;23:564–72. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791511001038
Jacobs JL, Coyne CB. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol. 2013;425:5009–19. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022283613006335
Vazquez C, Horner SM. MAVS coordination of antiviral innate immunity. J Virol. 2015;89:6974–7. Available from: http://jvi.asm.org/lookup/doi/10.1128/JVI.01918-14
Chan YK, Gack MU. RIG-I-like receptor regulation in virus infection and immunity. Curr Opin Virol. 2015;12:7–14. Available from: http://linkinghub.elsevier.com/retrieve/pii/S187962571500005X
Zevini A, Olagnier D, Hiscott J. Crosstalk between cytoplasmic RIG-I and STING sensing pathways. Trends Immunol. 2017;38(3):194–205. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28073693
Liu Y, Olagnier D, Lin R. Host and viral modulation of RIG-I-mediated antiviral immunity. Front Immunol. 2017;7:662. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28096803
Loo Y-M, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011;34:680–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21616437
Yao H, Dittmann M, Peisley A, Hoffmann H-H, Gilmore RH, Schmidt T, et al. ATP-dependent effector-like functions of RIG-I-like receptors. Mol Cell. 2015;58:541–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25891073
Franchi L, Eigenbrod T, Muñoz-Planillo R, Ozkurede U, Kim Y-G, Chakrabarti A, et al. Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux. J Immunol. 2014;193:4214–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25225670
Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway. Cell Death Differ. 2017;24(4):615–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28060376
Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, et al. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc Natl Acad Sci U S A. 2016;113:2241–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26858407
Laessig C, Hopfner K-P. Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors. J Biol Chem. 2017;jbc.R117.788398. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28411239
Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788–92. Available from: http://www.nature.com/doifinder/10.1038/nature08476
Zhong B, Zhang L, Lei C, Li Y, Mao A-P, Yang Y, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity. 2009;30:397–407. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19285439
Sun W, Li Y, Chen L, Chen H, You F, Zhou X, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci U S A. 2009;106:8653–8. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.0900850106
Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478:515–8. Available from: http://www.nature.com/doifinder/10.1038/nature10429
Barber GN. STING: infection, inflammation and cancer. Nat Rev Immunol. 2015;15:760–70. Available from: http://www.nature.com/doifinder/10.1038/nri3921
Liu X, Wang C. The emerging roles of the STING adaptor protein in immunity and diseases. Immunology. 2016;147:285–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26643733
Sauer J-D, Sotelo-Troha K, von Moltke J, Monroe KM, Rae CS, Brubaker SW, et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun. 2011;79:688–94. Available from: http://iai.asm.org/cgi/doi/10.1128/IAI.00999-10
Ahn J, Barber GN. Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease. Curr Opin Immunol. 2014;31:121–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791514001332
Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27:96–108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27981969
Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339:826–30. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1229963
Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786–91. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1232458
Liang Q, Seo GJ, Choi YJ, Kwak M-J, Ge J, Rodgers MA, et al. Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell Host Microbe. 2014;15:228–38. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1931312814000328
Cai X, Chiu Y-H, Chen ZJ. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell. 2014;54:289–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24766893
Ablasser A, Gulen MF. The role of cGAS in innate immunity and beyond. J Mol Med. 2016;94:1085–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27154323
Tao J, Zhou X, Jiang Z. cGAS-cGAMP-STING: the three musketeers of cytosolic DNA sensing and signaling. IUBMB Life. 2016;68:858–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27706894
Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nat Immunol. 2016;17:1142–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27648547
Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155:688–98. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867413012233
Gao D, Wu J, Wu Y-T, Du F, Aroh C, Yan N, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013;341:903–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23929945
Liu S, Feng M, Guan W. Mitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond. Int J Cancer. 2016;139:736–41. Available from: http://doi.wiley.com/10.1002/ijc.30074
White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159:1549–62. Available from: http://linkinghub.elsevier.com/retrieve/pii/S009286741401513X
Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS J. 2005;272:6179–217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16336259
Mayer S, Raulf M-K, Lepenies B. C-type lectins: their network and roles in pathogen recognition and immunity. Histochem Cell Biol. 2017;147:223–37. Available from: http://link.springer.com/10.1007/s00418-016-1523-7
Dambuza IM, Brown GD. C-type lectins in immunity: recent developments. Curr Opin Immunol. 2015;32:21–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25553393
Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol. 2008;9:1179–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18776906
Plato A, Hardison SE, Brown GD. Pattern recognition receptors in antifungal immunity. Semin Immunopathol. 2015;37:97–106. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25420452
Drummond RA, Brown GD. Signalling C-Type lectins in antimicrobial immunity. PLoS Pathog. 2013;9:e1003417. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23935480
Iborra S, Sancho D. Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors. Immunobiology. 2015;220:175–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25269828
Kiyotake R, Oh-hora M, Ishikawa E, Miyamoto T, Ishibashi T, Yamasaki S. Human mincle binds to cholesterol crystals and triggers innate immune responses. J Biol Chem. 2015;290:25322–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26296894
Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol. 2012;30:491–529. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22224766
Sancho D, Reis e Sousa C. Sensing of cell death by myeloid C-type lectin receptors. Curr Opin Immunol. 2013;25:46–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23332826
Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, et al. Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse”. Nature. 2011;472:471–5. Available from: http://www.nature.com/doifinder/10.1038/nature10071
Zhang J-G, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity. 2012;36:646–57. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761312001276
Srinivasan N, Gordon O, Ahrens S, Franz A, Deddouche S, Chakravarty P, et al. Actin is an evolutionarily-conserved damage-associated molecular pattern that signals tissue injury in Drosophila melanogaster. elife. 2016. https://doi.org/10.7554/eLife.19662. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27871362
Neumann K, Castiñeiras-Vilariño M, Höckendorf U, Hannesschläger N, Lemeer S, Kupka D, et al. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Immunity. 2014;40:389–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24631154
Kerscher B, Willment JA, Brown GD. The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol. 2013;25:271–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23606632
Bongarzone S, Savickas V, Luzi F, Gee AD. Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective. J Med Chem. 2017;60:7213–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28482155
Hudson BI, Lippman ME. Targeting RAGE signaling in inflammatory disease. Annu Rev Med. 2018;69:annurev-med-041316-085215. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29106804
Luttrell LM. GPCR signaling rides a wave of conformational changes. Cell. 2016;167:602–3. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867416313873
Luttrell LM, Gesty-Palmer D, Sibley DR. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev. 2010;62:305–30. Available from: http://pharmrev.aspetjournals.org/cgi/doi/10.1124/pr.109.002436
Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639–50. Available from: http://www.nature.com/doifinder/10.1038/nrm908
Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, et al. An atypical addition to the chemokine receptor nomenclature: IUPHAR review 15. Br J Pharmacol. 2015;172:3945–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25958743
Thomsen ARB, Plouffe B, Cahill TJ, Shukla AK, Tarrasch JT, Dosey AM, et al. GPCR-G protein-β-arrestin super-complex mediates sustained G protein signaling. Cell. 2016;166:907–19. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867416309102
Liu J, Cao X. Cellular and molecular regulation of innate inflammatory responses. Cell Mol Immunol. 2016;13:711–21. Available from: http://www.nature.com/doifinder/10.1038/cmi.2016.58
Ostrop J, Lang R. Contact, collaboration, and conflict: signal integration of Syk-coupled C-type lectin receptors. J Immunol. 2017;198:1403–14. Available from: http://www.jimmunol.org/lookup/doi/10.4049/jimmunol.1601665
Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12191486
Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440:228–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16407890
Kanneganti T-D, Ozören N, Body-Malapel M, Amer A, Park J-H, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006;440:233–6. Available from: http://www.nature.com/doifinder/10.1038/nature04517
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16407889
Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397–411. Available from: http://www.nature.com/doifinder/10.1038/nri3452
de Zoete MR, Palm NW, Zhu S, Flavell RA. Inflammasomes. Cold Spring Harb Perspect Biol. 2014;6:a016287. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a016287
Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–22. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867414004759
Kono H, Kimura Y, Latz E. Inflammasome activation in response to dead cells and their metabolites. Curr Opin Immunol. 2014;30:91–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25282339
Guo H, Callaway JB, Ting JP-Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677–87. Available from: http://www.nature.com/doifinder/10.1038/nm.3893
Vanaja SK, Rathinam VAK, Fitzgerald KA. Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol. 2015;25:308–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25639489
Man SM, Kanneganti T-D. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25879280
Broggi A, Granucci F. Microbe- and danger-induced inflammation. Mol Immunol. 2015;63:127–33. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161589014001680
Jo E-K, Kim JK, Shin D-M, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148–59. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26549800
Man SM, Kanneganti T-D. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16:7–21. Available from: http://www.nature.com/doifinder/10.1038/nri.2015.7
Próchnicki T, Mangan MS, Latz E. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Research. 2016;5:1–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27508077
Pellegrini C, Antonioli L, Lopez-Castejon G, Blandizzi C, Fornai M. Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation. Front Immunol. 2017;8:36. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2017.00036/full
Yu J-W, Lee M-S. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch Pharm Res. 2016;39(11):1503–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27600432
Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265:35–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25879282
Sharma D, Kanneganti T-D. The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation. J Cell Biol. 2016;213:617–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27325789
Man SM, Karki R, Briard B, Burton A, Gingras S, Pelletier S, et al. Differential roles of caspase-1 and caspase-11 in infection and inflammation. Sci Rep. 2017;7:45126. Available from: http://www.nature.com/articles/srep45126
He W, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015;25:1285–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26611636
Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26375003
Vince JE, Silke J. The intersection of cell death and inflammasome activation. Cell Mol Life Sci. 2016;73:2349–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27066895
Man SM, Kanneganti T-D. Gasdermin D: the long-awaited executioner of pyroptosis. Cell Res. 2015;25:1183–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26482951
Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2016;42(4):245–54. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0968000416301827
Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23809161
Yaron JR, Gangaraju S, Rao MY, Kong X, Zhang L, Su F, et al. K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis. 2015;6:e1954. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26512962
Di Virgilio F, Vuerich M. Purinergic signaling in the immune system. Auton Neurosci. 2015;191:117–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25979766
Gallo PM, Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol. 2013;4:138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23772226
Carta S, Penco F, Lavieri R, Martini A, Dinarello CA, Gattorno M, et al. Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance. Proc Natl Acad Sci U S A. 2015;112:2835–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25730877
Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol. 2010;22:28–33. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791509002271
Yang M, Hearnden CHA, Oleszycka E, Lavelle EC. NLRP3 inflammasome activation and cytotoxicity induced by particulate adjuvants. Methods Mol Biol. 2013;1040:41–63. Available from: http://link.springer.com/10.1007/978-1-62703-523-1_5
Conos SA, Chen KW, De Nardo D, Hara H, Whitehead L, Núñez G, et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci U S A. 2017;114:E961–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28096356
Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol. 2014;5:352. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25324778
Santos CXC, Tanaka LY, Wosniak J, Laurindo FRM. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal. 2009;11:2409–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19388824
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11:136–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20023662
Kim S, Joe Y, Jeong SO, Zheng M, Back SH, Park SW, et al. Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways. Innate Immun. 2014;20:799–815. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24217221
Bronner DN, Abuaita BH, Chen X, Fitzgerald KA, Nuñez G, He Y, et al. Endoplasmic reticulum stress activates the inflammasome via NLRP3- and caspase-2-driven mitochondrial damage. Immunity. 2015;43:451–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26341399
He Y, Zeng MY, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354–7. Available from: http://www.nature.com/doifinder/10.1038/nature16959
Schmid-Burgk JL, Chauhan D, Schmidt T, Ebert TS, Reinhardt J, Endl E, et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J Biol Chem. 2016;291:103–9. Available from: http://www.jbc.org/lookup/doi/10.1074/jbc.C115.700492
Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17:250–8. Available from: http://www.nature.com/doifinder/10.1038/ni.3333
Liston A, Masters SL. Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat Rev Immunol. 2017;17(3):208–14. Available from: http://www.nature.com/doifinder/10.1038/nri.2016.151
Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117–21. Available from: http://www.nature.com/doifinder/10.1038/nature10558
Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514:187–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25119034
Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 requires the Pannexin-1 channel and the Purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015;43:923–32. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761315004094
Gaidt MM, Hornung V. Alternative inflammasome activation enables IL-1β release from living cells. Curr Opin Immunol. 2017;44:7–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27842238
Liao K-C, Mogridge J. Activation of the Nlrp1b inflammasome by reduction of cytosolic ATP. Infect Immun. 2013;81:570–9. Available from: http://iai.asm.org/cgi/doi/10.1128/IAI.01003-12
Chavarría-Smith J, Mitchell PS, Ho AM, Daugherty MD, Vance RE. Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 inflammasome activation. PLoS Pathog. 2016;12:e1006052. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27926929
Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A. 2010;107:3076–80. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.0913087107
Vance RE. The NAIP/NLRC4 inflammasomes. Curr Opin Immunol. 2015;32:84–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25621709
Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol. 2009;10:266–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19158679
Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 2009;458:509–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19158676
Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458:514–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19158675
Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 2009;323:1057–60. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1169841
Man SM, Karki R, Kanneganti T-D. AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur J Immunol. 2016;46:269–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26626159
Luecke S, Paludan SR. Molecular requirements for sensing of intracellular microbial nucleic acids by the innate immune system. Cytokine. 2017;98:4–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27751656
Jakobs C, Perner S, Hornung V. AIM2 drives joint inflammation in a self-DNA triggered model of chronic polyarthritis. PLoS One. 2015;10:e0131702. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26114879
Di Micco A, Frera G, Lugrin J, Jamilloux Y, Hsu E-T, Tardivel A, et al. AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity. Proc Natl Acad Sci U S A. 2016;113:E4671–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27462105
Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L, et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity. 2012;36:561–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22483801
Li H, Wang J, Wang J, Cao L-S, Wang Z-X, Wu J-W. Structural mechanism of DNA recognition by the p202 HINa domain: insights into the inhibition of Aim2-mediated inflammatory signalling. Acta Crystallogr Sect F, Struct Biol Commun. 2014;70:21–9. Available from: http://scripts.iucr.org/cgi-bin/paper?S2053230X1303135X
Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, Vos MR, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156:1193–206. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867414002001
Meunier E, Wallet P, Dreier RF, Costanzo S, Anton L, Rühl S, et al. Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat Immunol. 2015;16:476–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25774716
Janowski AM, Sutterwala FS. Atypical inflammasomes. Methods Mol Biol. 2016;1417:45–62. Available from: http://link.springer.com/10.1007/978-1-4939-3566-6_2
Levy M, Shapiro H, Thaiss CA, Elinav E. NLRP6: a multifaceted innate immune sensor. Trends Immunol. 2017;38(4):248–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28214100
Levy M, Thaiss CA, Zeevi D, Dohnalová L, Zilberman-Schapira G, Mahdi JA, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell. 2015;163:1428–43. Available from: http://linkinghub.elsevier.com/retrieve/pii/S009286741501404X
Sun Y, Zhang M, Chen C-C, Gillilland M, Sun X, El-Zaatari M, et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology. 2013;144:1478–87, 1487–8. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0016508513002874
Williams KL, Lich JD, Duncan JA, Reed W, Rallabhandi P, Moore C, et al. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem. 2005;280:39914–24. Available from: http://www.jbc.org/cgi/doi/10.1074/jbc.M502820200
Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 2012;36:742–54. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761312001318
Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, et al. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol. 2007;178:1256–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17237370
Chelbi ST, Dang AT, Guarda G. Emerging major histocompatibility complex class I-related functions of NLRC5. Adv Immunol. 2017;133:89–119. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28215281
Benkő S, Kovács EG, Hezel F, Kufer TA. NLRC5 functions beyond MHC I regulation—what do we know so far? Front Immunol. 2017;8:150. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28261210
Lander ES. The heroes of CRISPR. Cell. 2016;164:18–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26771483
Diner BA, Lum KK, Cristea IM. The emerging role of nuclear viral DNA sensors. J Biol Chem. 2015;290:26412–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26354430
Horan KA, Hansen K, Jakobsen MR, Holm CK, Søby S, Unterholzner L, et al. Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol. 2013;190:2311–9. Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1202749
Morrone SR, Wang T, Constantoulakis LM, Hooy RM, Delannoy MJ, Sohn J. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc Natl Acad Sci U S A. 2014;111:E62–71. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.1313577111
Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe. 2011;9:363–75. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1931312811001302
Singh VV, Kerur N, Bottero V, Dutta S, Chakraborty S, Ansari MA, et al. Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes. J Virol. 2013;87:4417–31. Available from: http://jvi.asm.org/cgi/doi/10.1128/JVI.03282-12
Yu J-W, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S, et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 2006;13:236–49. Available from: http://www.nature.com/doifinder/10.1038/sj.cdd.4401734
Xu H, Yang J, Gao W, Li L, Li P, Zhang L, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014;513:237–41. Available from: http://www.nature.com/doifinder/10.1038/nature13449
Netea MG, van de Veerdonk FL, van der Meer JWM, Dinarello CA, Joosten LAB. Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol. 2015;33:49–77. Available from: http://www.annualreviews.org/doi/10.1146/annurev-immunol-032414-112306
da Silva WC, Oshiro TM, de Sá DC, Franco DDGS, Festa Neto C, Pontillo A. Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression. Cancer Genet. 2016;209:474–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27810076
Cheng C-H, Lee Y-S, Chang C-J, Lin J-C, Lin T-Y. Genetic polymorphisms in inflammasome-dependent innate immunity among pediatric patients with severe renal parenchymal infections. PLoS One. 2015;10:e0140128. Available from: http://dx.plos.org/10.1371/journal.pone.0140128
Thomson AW, Lotze MT. The cytokine handbook. New York: Academic Press; 2003. Available from: http://www.sciencedirect.com/science/book/9780126896633
Yoshimoto T. Cytokine frontiers: regulation of immune responses in health and disease. Japan: Springer; 2014. https://doi.org/10.1007/978-4-431-54442-5. ISBN: 9784431544425
Dembic Z. Chapter 1 – Introduction—Common features about cytokines. In: Dembic Z, editor. The cytokines of the immune system. London: Academic; 2015. p. 1–16. https://doi.org/10.1016/B978-0-12-419998-9.00001-8. ISBN:9780124199989.
Berezin VA (Vladimir A, Walmod PS. Cell adhesion molecules: implications in neurological diseases. Springer; New York 2014. ISBN:1461480892
Marks F, Fürstenberger G. Prostaglandins, leukotrienes, and other eicosanoids: from biogenesis to clinical application. Weinheim: Wiley-VCH; 1999. ISBN:3527613633
Lee MCS, Miller EA, Goldberg J, Orci L, Schekman R. Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol. 2004;20:87–123. Available from: http://www.annualreviews.org/doi/10.1146/annurev.cellbio.20.010403.105307
Bhattacharya A, Prakash YS, Eissa NT. Secretory function of autophagy in innate immune cells. Cell Microbiol. 2014;16:1637–45. Available from: http://doi.wiley.com/10.1111/cmi.12365
Stow JL, Murray RZ. Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor Rev. 2013;24:227–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23647915
Murray RZ, Stow JL. Cytokine secretion in macrophages: SNAREs, Rabs, and membrane trafficking. Front Immunol. 2014;5:538. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25386181
De Matteis MA, Luini A. Exiting the Golgi complex. Nat Rev Mol Cell Biol. 2008;9:273–84. Available from: http://www.nature.com/doifinder/10.1038/nrm2378
Alabi AA, Tsien RW. Perspectives on kiss-and-run: role in exocytosis, endocytosis, and neurotransmission. Annu Rev Physiol. 2013;75:393–422. Available from: http://www.annualreviews.org/doi/10.1146/annurev-physiol-020911-153305
Vardjan N, Jorgačevski J, Zorec R. Fusion pores, SNAREs, and exocytosis. Neuroscience. 2013;19:160–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23019088
Chiaruttini G, Piperno GM, Jouve M, De Nardi F, Larghi P, Peden AA, et al. The SNARE VAMP7 regulates exocytic trafficking of interleukin-12 in dendritic cells. Cell Rep. 2016;14:2624–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26972013
Collins LE, DeCourcey J, Soledad di Luca M, Rochfort KD, Loscher CE. An emerging role for SNARE proteins in dendritic cell function. Front Immunol. 2015;6:133. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00133/abstract
Zhu H, Wang L, Ruan Y, Zhou L, Zhang D, Min Z, et al. An efficient delivery of DAMPs on the cell surface by the unconventional secretion pathway. Biochem Biophys Res Commun. 2011;404:790–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21168385
Daniels M, Brough D. Unconventional pathways of secretion contribute to inflammation. Int J Mol Sci. 2017;18:102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28067797
Malhotra V. Unconventional protein secretion: an evolving mechanism. EMBO J. 2013;32:1660–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23665917
Robinson DG, Ding Y, Jiang L. Unconventional protein secretion in plants: a critical assessment. Protoplasma. 2016;253:31–43. Available from: http://link.springer.com/10.1007/s00709-015-0887-1
Pompa A, De Marchis F, Pallotta MT, Benitez-Alfonso Y, Jones A, Schipper K, et al. Unconventional transport routes of soluble and membrane proteins and their role in developmental biology. Int J Mol Sci. 2017;18:703. Available from: http://www.mdpi.com/1422-0067/18/4/703
Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol. 2009;10:148–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19122676
Richards AL, Jackson WT. Intracellular vesicle acidification promotes maturation of infectious poliovirus particles. PLoS Pathog. 2012;8:e1003046. Available from: http://dx.plos.org/10.1371/journal.ppat.1003046
Martín-Sánchez F, Diamond C, Zeitler M, Gomez AI, Baroja-Mazo A, Bagnall J, et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ. 2016;23:1219–31. Available from: http://www.nature.com/doifinder/10.1038/cdd.2015.176
Li HS, Watowich SS. Innate immune regulation by STAT-mediated transcriptional mechanisms. Immunol Rev. 2014;261:84–101. Available from: http://doi.wiley.com/10.1111/imr.12198
Liao W, Lin J-X, Leonard WJ. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity. 2013;38:13–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761313000113
Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 2010;33:153–65. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761310002876
Yu A, Zhu L, Altman NH, Malek TR. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity. 2009;30:204–17. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761309000661
Luzina IG, Keegan AD, Heller NM, Rook GAW, Shea-Donohue T, Atamas SP. Regulation of inflammation by interleukin-4: a review of “alternatives”. J Leukoc Biol. 2012;92:753–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22782966
Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol. 2013;31:317–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23298208
Paul WE. History of interleukin-4. Cytokine. 2015;75:3–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25814340
McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429–42. Available from: http://www.nature.com/doifinder/10.1038/nri2094
Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by γc family cytokines. Nat Rev Immunol. 2009;9:480–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19543225
Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One. 2011;6:e17739. Available from: http://dx.plos.org/10.1371/journal.pone.0017739
Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, Bonder CS, et al. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol Rev. 2012;250:277–302. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23046136
Papatriantafyllou M. Cytokines: GM-CSF in focus. Nat Rev Immunol. 2011;11:370–1. Available from: http://www.nature.com/doifinder/10.1038/nri2996
Kelly EA, Esnault S, Johnson SH, Liu LY, Malter JS, Burnham ME, et al. Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. Immunol Cell Biol. 2016;94:701–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27001469
Lotz M. Interleukin-6: a comprehensive review. Cancer Treat Res. 1995;80:209–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8821579
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25190079
Morieri ML, Passaro A, Zuliani G. Interleukin-6 “trans-signaling” and ischemic vascular disease: the important role of soluble gp130. Mediat Inflamm. 2017;2017:1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28250574
Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19:641–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14614851
Vignali DAA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13:722–8. Available from: http://www.nature.com/doifinder/10.1038/ni.2366
Renauld J-C. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol. 2003;3:667–76. Available from: http://www.nature.com/doifinder/10.1038/nri1153
Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15546383
Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15032600
Shen X-D, Ke B, Ji H, Gao F, Freitas MCS, Chang WW, et al. Disruption of type-I IFN pathway ameliorates preservation damage in mouse orthotopic liver transplantation via HO-1 dependent mechanism. Am J Transplant. 2012;12:1730–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22429450
Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207:2053–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20837696
Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36–49. Available from: http://www.nature.com/doifinder/10.1038/nri3581
McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25614319
Hertzog PJ, Williams BRG. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 2013;24:217–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1359610113000300
Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen HAR. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses. Cytokine Growth Factor Rev. 2016;29:71–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27053489
Chen K, Liu J, Cao X. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. 2017;83:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28330758
Fenimore J, Young HA. Regulation of IFN-γ expression. Adv Exp Med Biol. 2016;941:1–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27734406
Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 1996;156:4274–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8666798
Murphy K, Weaver C. Janeway’s IMMUNOBIOLOGY. 9th ed. New York: Garland Science, Taylor and Francis Group; 2016. Available from: http://www.garlandscience.com/product/isbn/9780815345053
Ahmed CM, Johnson HM. The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis. JAKSTAT. 2013;2:e26227. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24416655
Kearney S, Delgado C, Lenz LL. Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections. Immunol Res. 2013;55:187–200. Available from: http://link.springer.com/10.1007/s12026-012-8362-y
Johnson HM, Ahmed CM. Noncanonical IFN signaling: mechanistic linkage of genetic and epigenetic events. Mediat Inflamm. 2016;2016:1–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28077919
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69–77. Available from: http://www.nature.com/doifinder/10.1038/ni875
Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4:63–8. Available from: http://www.nature.com/doifinder/10.1038/ni873
Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol. 2007;81:7749–58. Available from: http://jvi.asm.org/cgi/doi/10.1128/JVI.02438-06
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45:164–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23291588
de Weerd NA, Nguyen T. The interferons and their receptors—distribution and regulation. Immunol Cell Biol. 2012;90:483–91. Available from: http://www.nature.com/doifinder/10.1038/icb.2012.9
Lazear HM, Nice TJ, Diamond MS. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity. 2015;43:15–28. Available from: http://linkinghub.elsevier.com/retrieve/pii/S107476131500268X
Hoffmann H-H, Schneider WM, Rice CM. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015;36:124–38. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1471490615000150
Odendall C, Kagan JC. The unique regulation and functions of type III interferons in antiviral immunity. Curr Opin Virol. 2015;12:47–52. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1879625715000279
Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205–18. Available from: http://doi.wiley.com/10.1111/j.1600-065X.2008.00706.x
Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18424693
Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. 2011;11:1563–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21668640
Wan X, Huang WJ, Chen W, Xie H-G, Wei P, Chen X, et al. IL-10 deficiency increases renal ischemia-reperfusion injury. Nephron Exp Nephrol. 2014;128:37–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25376659
Rojas JM, Avia M, Martín V, Sevilla N. IL-10: a multifunctional cytokine in viral infections. J Immunol Res. 2017;2017:1–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28316998
Fouda AY, Pillai B, Dhandapani KM, Ergul A, Fagan SC. Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. Eur J Pharmacol. 2017;799:128–34. Available from: http://linkinghub.elsevier.com/retrieve/pii/S001429991730081X
Mingomataj EÇ, Bakiri AH. Regulator versus effector paradigm: interleukin-10 as indicator of the switching response. Clin Rev Allergy Immunol. 2016;50:97–113. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26450621
Villalta SA, Rosenthal W, Martinez L, Kaur A, Sparwasser T, Tidball JG, et al. Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Sci Transl Med. 2014;6:258ra142. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25320234
Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T Cell induction in man. Front Immunol. 2015;6:569. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00569/abstract
Wortel C, Heidt S. Regulatory B cells: phenotype, function and role in transplantation. Transpl Immunol. 2017;41:1–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28257995
Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res. 1999;19:563–73. Available from: http://www.liebertonline.com/doi/abs/10.1089/107999099313695
Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol. 2008;121:1108–11. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0091674908004107
Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O’Neill L, et al. IL-1 family nomenclature. Nat Immunol. 2010;11:973. Available from: http://www.nature.com/doifinder/10.1038/ni1110-973
Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39:1003–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24332029
Garlanda C, Riva F, Bonavita E, Mantovani A. Negative regulatory receptors of the IL-1 family. Semin Immunol. 2013;25:408–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24239046
Martin SJ. Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system. FEBS J. 2016;283:2599–615. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27273805
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50. Available from: http://www.annualreviews.org/doi/10.1146/annurev.immunol.021908.132612
Borthwick LA. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol. 2016;38:517–34. Available from: http://link.springer.com/10.1007/s00281-016-0559-z
Cohen I, Rider P, Carmi Y, Braiman A, Dotan S, White MR, et al. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci U S A. 2010;107:2574–9. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.0915018107
Land WG, Agostinis P, Gasser S, Garg AD, Linkermann A. Transplantation and damage-associated molecular patterns (DAMPs). Am J Transplant. 2016;16:3338–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27421829
Kesavardhana S, Kanneganti T-D. Mechanisms governing inflammasome activation, assembly and pyroptosis induction. Int Immunol. 2017;29:201–10. Available from: https://academic.oup.com/intimm/article-lookup/doi/10.1093/intimm/dxx018
Qiu S, Liu J, Xing F. “Hints” in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death. Cell Death Differ. 2017;24:588–96. Available from: http://www.nature.com/doifinder/10.1038/cdd.2017.24
Gutierrez KD, Davis MA, Daniels BP, Olsen TM, Ralli-Jain P, Tait SWG, et al. MLKL activation triggers NLRP3-mediated processing and release of IL-1β independently of gasdermin-D. J Immunol. 2017;198:2156–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28130493
Dower SK, Kronheim SR, Hopp TP, Cantrell M, Deeley M, Gillis S, et al. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature. 1986;324:266–8. Available from: http://www.nature.com/doifinder/10.1038/324266a0
Wawrocki S, Druszczynska M, Kowalewicz-Kulbat M, Rudnicka W. Interleukin 18 (IL-18) as a target for immune intervention. Acta Biochim Pol. 2016;63:59–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26885772
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both TH1 and TH2 responses. Annu Rev Immunol. 2001;19:423–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11244043
Carta S, Lavieri R, Rubartelli A. Different members of the IL-1 family come out in different ways: DAMPs vs. cytokines? Front Immunol. 2013;4:123. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00123/abstract
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479–90. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761305003110
Moussion C, Ortega N, Girard J-P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel “alarmin”? PLoS One. 2008;3:e3331. Available from: http://dx.plos.org/10.1371/journal.pone.0003331
Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10:103–10. Available from: http://www.nature.com/doifinder/10.1038/nri2692
Cayrol C, Girard J-P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791514001101
Xu H, Turnquist HR, Hoffman R, Billiar TR. Role of the IL-33-ST2 axis in sepsis. Mil Med Res. 2017;4:3. Available from: http://mmrjournal.biomedcentral.com/articles/10.1186/s40779-017-0115-8
Hahn M, Frey S, Hueber AJ. The novel interleukin-1 cytokine family members in inflammatory diseases. Curr Opin Rheumatol. 2017;29:208–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27926540
Kumar S, McDonnell PC, Lehr R, Tierney L, Tzimas MN, Griswold DE, et al. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem. 2000;275:10308–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10744718
Gao W, Kumar S, Lotze MT, Hanning C, Robbins PD, Gambotto A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J Immunol. 2003;170:107–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12496389
Rudloff I, Godsell J, Nold-Petry CA, Harris J, Hoi A, Morand EF, et al. Brief report: Interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus. Arthritis Rheumatol (Hoboken NJ). 2015;67:3219–25. Available from: http://doi.wiley.com/10.1002/art.39328
Pang IK, Ichinohe T, Iwasaki A. IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8+ T cell responses to influenza A virus. Nat Immunol. 2013;14:246–53. Available from: http://www.nature.com/doifinder/10.1038/ni.2514
Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119:651–65. Available from: http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-04-325225
Sedger LM, McDermott MF. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014;25:453–72. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1359610114000781
Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362–74. Available from: http://www.nature.com/doifinder/10.1038/nri3834
Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49–62. Available from: http://www.nature.com/doifinder/10.1038/nrrheum.2015.169
Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS crosstalk in inflammation. Trends Cell Biol. 2016;26:249–61. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0962892415002494
Adrain C, Zettl M, Christova Y, Taylor N, Freeman M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science. 2012;335:225–8. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1214400
McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK, et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science. 2012;335:229–32. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1214448
Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10:479–89. Available from: http://www.nature.com/doifinder/10.1038/nri2800
Shabgah AG, Fattahi E, Shahneh FZ. Interleukin-17 in human inflammatory diseases. Adv Dermatol Allergol. 2014;4:256–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25254011
Sharma J, Balakrishnan L, Datta KK, Sahasrabuddhe NA, Khan AA, Sahu A, et al. A knowledgebase resource for interleukin-17 family mediated signaling. J Cell Commun Signal. 2015;9:291–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26077014
Song X, He X, Li X, Qian Y. The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Cell Mol Immunol. 2016;13:418–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27018218
Miossec P. Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD Open. 2017;3:e000284. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28243466
Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120:331–42. Available from: http://www.jci.org/articles/view/38702
Feng M, Li G, Qian X, Fan Y, Huang X, Zhang F, et al. IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion. Int Immunopharmacol. 2012;13:135–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22465963
Zhu H, Li J, Wang S, Liu K, Wang L, Huang L. Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model. Transp J. 2013;95:1448–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23677049
Tsai H-C, Velichko S, Hung L-Y, Wu R. IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin Dev Immunol. 2013;2013:1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23956759
Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–21. Available from: http://doi.wiley.com/10.1111/j.1365-2567.2009.03240.x
Land WG. Chronic allograft dysfunction: a model disorder of innate immunity. Biom J. 2013;36:209–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24225188
Li MO, Wan YY, Sanjabi S, A-KL R, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99–146. Available from: http://www.annualreviews.org/doi/10.1146/annurev.immunol.24.021605.090737
Hinck AP, Mueller TD, Springer TA. Structural biology and evolution of the TGF-β family. Cold Spring Harb Perspect Biol. 2016;8:a022103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27638177
Hata A, Chen Y-G. TGF-β signaling from receptors to Smads. Cold Spring Harb Perspect Biol. 2016;8:a022061. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27449815
Moses HL, Roberts AB, Derynck R. The discovery and early days of TGF-β: a historical perspective. Cold Spring Harb Perspect Biol. 2016;8:a021865. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27328871
Kelly A, Houston SA, Sherwood E, Casulli J, Travis MA. Regulation of innate and adaptive immunity by TGFβ. Adv Immunol. 2017;134:137–233. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0065277617300019
Morikawa M, Derynck R, Miyazono K. TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 2016;8:a021873. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a021873
Chang C. Agonists and antagonists of TGF-β family ligands. Cold Spring Harb Perspect Biol. 2016;8:a021923. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a021923
DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol. 1996;148:1851–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8669471
Li Y, Qi X, Tong X, Wang S. Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway. Cell Mol Immunol. 2013;10:506–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23954950
Cheng M, Liu H, Zhang D, Liu Y, Wang C, Liu F, et al. HMGB1 enhances the AGE-induced expression of CTGF and TGF-β via RAGE-dependent signaling in renal tubular epithelial cells. Am J Nephrol. 2015;41:257–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25924590
Pittet J-F, Koh H, Fang X, Iles K, Christiaans S, Anjun N, et al. HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1. PLoS One. 2013;8:e63907. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23696858
Markovics JA, Araya J, Cambier S, Somanath S, Gline S, Jablons D, et al. Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture. J Biol Chem. 2011;286:36864–74. Available from: http://www.jbc.org/cgi/doi/10.1074/jbc.M111.276790
Yan X, Chen Y-G. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J. 2011;434:1–10. Available from: http://biochemj.org/lookup/doi/10.1042/BJ20101827
Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma. 2012;2:18–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22928164
Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv Wound Care. 2013;2:195–214. Available from: http://online.liebertpub.com/doi/abs/10.1089/wound.2013.0429
Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, et al. Transforming growth factor β (TGF-β) and autoimmunity. Autoimmun Rev. 2005;4:450–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S156899720500042X
Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–38. Available from: http://www.nature.com/doifinder/10.1038/nrneph.2016.48
Seoane J, Gomis RR. TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol. 2017;2017:a022277. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28246180
Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994;42:1417–25. Available from: http://journals.sagepub.com/doi/10.1177/42.11.7523489
Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol. 2006;533:327–40. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0014299905014007
Carpenter G, Liao H-J. Receptor tyrosine kinases in the nucleus. Cold Spring Harb Perspect Biol. 2013;5:a008979. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24086039
Liang J, Wu Y-L, Chen B-J, Zhang W, Tanaka Y, Sugiyama H. The C-Kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci. 2013;9:435–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23678293
Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006;7:243. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17201934
Graves DT, Jiang Y. Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med. 1995;6:109–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7548618
Kufareva I, Salanga CL, Handel TM. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol. 2015;93:372–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25708536
Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22633458
Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 2015;7:a016303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25635046
Tecchio C, Cassatella MA. Neutrophil-derived chemokines on the road to immunity. Semin Immunol. 2016;28:119–28. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1044532316300173
Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, et al. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2014;66:1–79. Available from: http://pharmrev.aspetjournals.org/cgi/doi/10.1124/pr.113.007724
Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998;273:23169–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9722546
Bryant VL, Slade CA. Chemokines, their receptors and human disease: the good, the bad and the itchy. Immunol Cell Biol. 2015;93:364–71. Available from: http://www.nature.com/doifinder/10.1038/icb.2015.23
Caronni N, Savino B, Recordati C, Villa A, Locati M, Bonecchi R. Cancer and chemokines. Methods Mol Biol. 2016;1393:87–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27033218
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15:405–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26027717
Langer HF, Chavakis T. Leukocyte - endothelial interactions in inflammation. J Cell Mol Med. 2009;13:1211–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19538472
Leow-Dyke S, Allen C, Denes A, Nilsson O, Maysami S, Bowie AG, et al. Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation. 2012;9:698. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23034047
Etzioni A, Selanikio JD. Adhesion molecules—their role in health and disease. Pediatr Res. 1996;39:191–8. Available from: http://www.nature.com/doifinder/10.1203/00006450-199604001-01156
Patel SJ, Jindal R, King KR, Tilles AW, Yarmush ML. The inflammatory response to double stranded DNA in endothelial cells is mediated by NFκB and TNFα. PLoS One. 2011;6:e19910. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21611132
Kourtzelis I, Mitroulis I, von Renesse J, Hajishengallis G, Chavakis T. From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins. J Leukoc Biol. 2017;jlb.3MR0117-024R. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292945
Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et al. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One. 2013;8:e59989. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23527291
Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15:511–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26139350
Metchnikoff E. Über eine Sprosspilzerkrankungder Daphniden. Beitrag zur Lehre der Phagocyten gegen Krankheitserreger. Virchows Arch für Pathol Anat und Physiol. 1884;96:177–93.
Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 1999;17:593–623. Available from: http://www.annualreviews.org/doi/10.1146/annurev.immunol.17.1.593
Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol. 2002;20:825–52. Available from: http://www.annualreviews.org/doi/10.1146/annurev.immunol.20.103001.114744
Greenberg S, Grinstein S. Phagocytosis and innate immunity. Curr Opin Immunol. 2002;14:136–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11790544
Aderem A. Phagocytosis and the inflammatory response. J Infect Dis. 2003;187:S340–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12792849
Freeman SA, Grinstein S. Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev. 2014;262:193–215. Available from: http://doi.wiley.com/10.1111/imr.12212
Flannagan RS, Jaumouillé V, Grinstein S. The cell biology of phagocytosis. Annu Rev Pathol Mech Dis. 2012;7:61–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21910624
Gordon S. Phagocytosis: an immunobiologic process. Immunity. 2016;44:463–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26982354
Green DR, Oguin TH, Martinez J. The clearance of dying cells: table for two. Cell Death Differ. 2016;23:1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26990661
Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol. 2009;10:609–22. Available from: http://www.nature.com/doifinder/10.1038/nrm2748
Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol. 2009;10:597–608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19696797
McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2011;12:517–33. Available from: http://www.nature.com/doifinder/10.1038/nrm3151
Goh LK, Sorkin A. Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol. 2013;5:a017459. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23637288
Di Fiore PP, von Zastrow M. Endocytosis, signaling, and beyond. Cold Spring Harb Perspect Biol. 2014;6:a016865. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a016865
Kirchhausen T, Owen D, Harrison SC. Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb Perspect Biol. 2014;6:a016725. Available from: http://cshperspectives.cshlp.org/lookup/doi/10.1101/cshperspect.a016725
Zhang X, Kim K-M. Multifactorial regulation of G protein-coupled receptor endocytosis. Biomol Ther (Seoul). 2017;25:26–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28035080
Kerr MC, Teasdale RD. Defining macropinocytosis. Traffic. 2009;10:364–71. Available from: http://doi.wiley.com/10.1111/j.1600-0854.2009.00878.x
Ha KD, Bidlingmaier SM, Liu B. Macropinocytosis exploitation by cancers and cancer therapeutics. Front Physiol. 2016;7:381. Available from: http://journal.frontiersin.org/Article/10.3389/fphys.2016.00381/abstract
Lim JP, Gleeson PA. Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol Cell Biol. 2011;89:836–43. Available from: http://www.nature.com/doifinder/10.1038/icb.2011.20
Bloomfield G, Kay RR. Uses and abuses of macropinocytosis. J Cell Sci. 2016;129:2697–705. Available from: http://jcs.biologists.org/lookup/doi/10.1242/jcs.176149
Rosales C, Uribe-Querol E. Phagocytosis: a fundamental process in immunity. Biomed Res Int. 2017;2017:1–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28691037
Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, Kerscher B, et al. The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity. Cell Host Microbe. 2015;17:252–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1931312815000244
Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell. 2001;106:675–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11572774
Ley K, Pramod AB, Croft M, Ravichandran KS, Ting JP. How mouse macrophages sense what is going on. Front Immunol. 2016;7:204. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2016.00204/abstract
Niedergang F, Di Bartolo V, Alcover A. Comparative anatomy of phagocytic and immunological synapses. Front Immunol. 2016;7:18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26858721
Levin R, Grinstein S, Canton J. The life cycle of phagosomes: formation, maturation, and resolution. Immunol Rev. 2016;273:156–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27558334
Elliott MR, Koster KM, Murphy PS. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J Immunol. 2017;198:1387–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28167649
Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev. 2016;273:357–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27558346
Han CZ, Ravichandran KS. Metabolic connections during apoptotic cell engulfment. Cell. 2011;147:1442–5. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867411015054
A-González N, Castrillo A. Liver X receptors as regulators of macrophage inflammatory and metabolic pathways. Biochim Biophys Acta Mol basis Dis. 2011;1812:982–94. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0925443910002930
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Land, W.G. (2018). Cellular Inflammatory Responses. In: Damage-Associated Molecular Patterns in Human Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78655-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-78655-1_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78654-4
Online ISBN: 978-3-319-78655-1
eBook Packages: MedicineMedicine (R0)